Scholars@Duke
Search form
Search
Advanced Search
Support
Index
Subscribe to Announcements
Menu
Search
Home
People
Schools / Institutes
Research
About
Home
People
Schools / Institutes
Research
A PHASE 2/3 TRIAL OF THE EFFICACY AND SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME
Administered By
Pediatrics, Nephrology
Awarded By
Reata Pharmaceuticals, Inc.
Contributors
Gbadegesin, Rasheed Adebayo
Principal Investigator
Start/End
January 5, 2018 - December 31, 2020